Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 3,139

Document Document Title
WO/1996/025376
4-Isobutylstyrene and other olefinic compounds corresponding to the formula C(R3)(R4)=C(R2)A are prepared by reacting an organic compound having the formula AX with a vinyl or substituted vinyl compound having the formula C(R3)(R4)=C(R2)...  
WO/1996/015087
This invention relates to a novel process which comprises feeding a mixture formed from diphenylethane and bromine to a stirrable reaction mass comprised of bromine and a bromination catalyst to yield a decabromodiphenylethane wet cake w...  
WO/1996/015096
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula (T)xA-B-D-E-G, ...  
WO/1996/013569
Disclosed is a single phase mixture of about 1 to about 99 wt% of a compound having general formula (I) where "n" is 1 or 2 and about 0.1 to about 99 wt% of a liquid which can be a perfluoro aliphatic alkane from C5 to C8, a perfluoro cy...  
WO/1996/011227
A preferred process for producing a brominated, non-fused aromatic composition involves a continuous bromination in a continuous, mixed reactor such as a continuous stirred tank reactor. Bromine and the aromatic substrate, and optionaly ...  
WO/1996/010003
The present invention relates to a novel process for preparing (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, also known in the art as (E)-(p-fluorophenethyl)-3-fluoroallylamine, novel intermediates thereof, a novel process fo...  
WO/1996/009272
A tetracyclic chlorobenzene derivative represented by general formula (I) and being suitable for use in active-matrix display elements and a liquid-crystal composition containing the same (wherein each of rings A, B and C independently r...  
WO/1996/008240
The present invention provides methods and product for inhibiting mammalian cell proliferation. Compounds that are anti-mycotics and that inhibit the Ca++-activated potassium channel of erythrocytes have been modified for use in the pres...  
WO/1996/008457
This invention relates to a novel process which comprises feeding a mixture formed from diphenylethane and bromine to a stirrable reaction mass comprised of bromine and a bromination catalyst to yield a decabromodiphenylethane wet cake w...  
WO/1996/006061
The invention relates to a novel and simple method for manufacturing laterally substituted chloroderivatives of formula (1) and 3,6-disubstituted cyclohex-2-en-1-ones being intermediates for their manufacturing. The chloroderivatives of ...  
WO/1996/005159
A liquid crystal medium based on a mixture of polar compounds with positive dielectric anisotropy is characterised in that it contains one or several compounds having the general formula (I), in which R, A1, A2, Z1, Z2, Y, L1 and m have ...  
WO/1996/003357
A process for the preparation of a selectively fluorinated organic compound, which process includes reaction of a precursor of said organic compound, the precursor containing at least one Group VI element selected from sulfur, selenium a...  
WO/1996/003356
A method of iodinating and/or brominating and/or chlorinating an aromatic compound which comprises the steps of reacting an iodinating agent and/or brominating agent and/or chlorinating agent with the aromatic compound in the presence of...  
WO/1996/001253
Certain compounds have been synthesized and found to be effective inhibitors of phospholipase A2 (PLA2), and thereby useful in the treatment of intestinal cholesterol absorption and the disease states arising therefrom, such as hyperchol...  
WO/1996/000710
The invention describes liquid crystal compounds of formula (I) which are suitable for use in liquid crystal devices including those devices which exploit the electroclinic effect. The compounds of formula (I) may also be used as chiral ...  
WO/1996/000208
Compounds have the general formula (I) Z[-Y1-(A-Y2)m-X]n, in which the variables have the following meanings: Z stands for an n-valent aliphatic residue with 2 to 20 C atoms or for an n-valent three to seven-membered saturated or unsatur...  
WO/1995/035283
Compounds of general formula (1) are described, formula wherein =W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m- [where m is zero or an integer of value 1 or 2], or -N(Rb)- [where Rb is a hyd...  
WO/1995/035281
Compounds of general formula (1) are described, wherein = W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m- [where m is zero or an integer of value 1 or 2], or -N(Rb)- [where Rb is a hydrogen a...  
WO/1995/032261
Fluoroalkyl ethinyl and difluoroalkyl ethinyl benzenes of formula (I) in which the symbols and indices have the following meanings: R1 is H, a straight chained or branched alkyl group (with or without an asymmetrical C atom) with 1 to 15...  
WO/1995/030723
Supertwist liquid crystal displays with outstanding properties are obtained when the nematic liquid crystal mixture contains at least one compound of formula (I), where R1, R2, (a), p, r and s are as indicated in claim 1.  
WO/1995/029886
The present invention concerns processes for preparing aromatic, bromine-containing compounds, novel bromine-containing compounds and their use as intermediate products in the synthesis of active agents. Processes according to the invent...  
WO/1995/021817
A class of substituted spiro compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (III), wherein n is a number selected from 0, 1 and 2; where...  
WO/1995/018848
The invention describes liquid crystal compounds of formula (I) which are suitable for use in liquid crystal devices including those devices which exploit the electroclinic effect, wherein X may be CN, NO2, CF3, CF2H, CFH2, halogen, hydr...  
WO/1995/016658
Disclosed is a process for preparing allylic halides of the formula (I), wherein X is Cl, Br or I, for use as intermediates in the synthesis of substituted tetrahydrofuran azole anti-fungal agents.  
WO/1995/016671
Methods of producing iodonium compounds by triflate-mediated iodonium transfer reactions are disclosed. Iodonium compounds sequester PQQ and inhibit PQQ-catalyzed cellular redox-cycling reactions involved in microbial metabolism and in h...  
WO/1995/013999
The invention concerns 3,5-difluorobenzenes of general formula (I) in which the symbols and indices are defined as follows: R1 is H, a straight-chain or branched-chain alkyl (with or without an asymmetric C-atom) with 1 to 15 C-atoms, wh...  
WO/1995/013257
The invention concerns 2,6-difluorobenzenes of general formula (I) in which the symbols and indices are defined as follows: R1 is H, a straight-chain or branched-chain alkyl (with or without an asymmetric C-atom) with 1 to 15 C-atoms, wh...  
WO/1995/011242
Compounds of formula (I), wherein m is 1-4; R1-R4 independently are hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, or I; R5 is hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, I, lower alkoxy or lower thioalkoxy of 1-6 carbons; R6 is h...  
WO/1995/010484
The chlorine or halide content in a chlorinated hydrocarbon or halogenated aromatic hydrocarbon in an environment which admits to the presence of air and moisture can be reduced by bringing the chlorinated hydrocarbon or halogenated arom...  
WO/1995/010496
2,3,4-trifluorobenzenes of formula (I), in which R1 is methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl or decyl and M is (a), (b), (c), (d), (e) or (f) in which X is -CH2-O- or -O-CH2, are suitable as components of nema...  
WO/1995/010495
2,3,4,5-tetrafluorobenzenes of formula (I), in which: R1 is H, a straight-chained or branched alkyl (with or without an asymmetrical C atom) with 1 to 15 C atoms, in which one or two non-adjacent -CH2- groups may also be substituted by -...  
WO/1995/009829
2,4-difluorobenzenes of general formula (1) in which: R1 is H, a straight-chained or branched alkyl (with or without an asymmetrical C atom) with 1 to 15 C atoms, in which one or two non-adjacent CH2 groups may also be replaced by -O-, -...  
WO/1995/009828
2,4,5-trifluorobenzenes of general formula (I) in which: R1 is H, a straight-chained or branched alkyl (with or without an asymmetrical C atom) with 1 to 15 or 3 to 15 C atoms, in which one or two non-adjacent CH2 groups may also be repl...  
WO/1995/007895
A process for making fluconazole comprising the steps shown above.  
WO/1995/004790
2-fluorocyclohexene derivatives of the formula (I) in which R, A1, Z1, X, L1, L2, m and n have the meanings given in claim (1) can be used as components of liquid crystalline media for electro-optical display components, especially for m...  
WO/1994/029243
Unsymmetrically substituted triphenylenes required in the synthesis of polymeric discotic liquid crystals are made using iron (III) chloride in organic solvent at room temperature to effect the oxidative coupling of 1,2-dialkoxybenzenes ...  
WO/1994/026839
Partially fluorinated benzene derivatives having formula (I) in which R, A1, A2, Z1, Z2, L1, L2 and m have the meanings given in the first claim are suitable as components of liquid crystal media.  
WO/1994/026687
Compounds of formula (I) wherein m is 1-4; R1-R4 independdently are hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, or I; R5 is hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, I, lower alkoxy or lower thioalkoxy of 1-6 carbons; R6 is h...  
WO/1994/024080
Non-steroidal compounds which are high affinity, high specificity ligands for progesterone receptors are disclosed. The compounds include synthetic derivatives of cyclocymopol and its diastereomers, spectroscopically and chromatographica...  
WO/1994/022978
Described are processes for preparing brominated diphenylalkane products which are far whiter than prior known brominated diphenylalkane products. The resultant white brominated diphenylalkane products also form a part of the present inv...  
WO/1994/020443
To provide a liquid crystal compound, a dicyclohexylethylene derivative, which has a wide liquid crystal phase temperaturerange, a low viscosity, a large DELTA value, a high stability, and an excellent compatibility with other liquid cry...  
WO/1994/020442
A fluorinated aromatic compound represented by formula (I), utilizable for preparing a magnetic fluid having a wide heat-resistant temperature range and a high water resistance. In said formula, X represents H, F, Cl, C1-C20 alkyl or C1-...  
WO/1994/018285
Indan derivates have formula (I), in which X1 and X2 independently represent H, F, Cl, CF3, CN, OCF3, OCF2H, alkyl or alkoxy having each up to 5 carbon atoms, P-Q is a simple or double bond and MG is a mesogenic group. Also disclosed is ...  
WO/1994/017018
A fullerene derivate has formula (I), in which the symbols and indexes have the following meaning: F is a fullerene residue having the formula (C20+2m), in which m equals 1 to 50; R1 to R8 are the same or different and represent H, CO2R9...  
WO/1994/012455
The invention relates to methylene cyclobutane-benzole derivatives of formula (I) in which R1, A1, Z1, L1, L2, m, V, W, Y and n have the meanings given in claim 1, and their use as components of liquid crystal media for electro-optical d...  
WO/1994/008978
Compounds having the structural formula (I), wherein R can be the same or different and is halogen, hydrogen, C1-C8 alkyl, C1-C8 haloalkyl, C3-C6 cycloalkyl, C7-C9 aralkyl, phenyl, nitro, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulfiny...  
WO/1994/006741
A pesticidal compound, suitable for combating soil borne insect pests has formula (I) in which ArA represents a phenyl or naphthyl group optionally substituted by one or more groups selected from halogen, alkoxy, haloalkoxy, methylenedio...  
WO/1994/005613
A difluoride derivative represented by the general formula: R1-(A1-Y1)m-A2-CF=CF-C=C-A3-(Y2-A4)n-R2, wherein A1 through A4 represent each trans-1,4-cyclohexylene, 1,4-cyclohexenylene or 1,4-phenylene; m and n represent each 0 or 1; and R...  
WO/1994/000423
A process is disclosed for preparing compounds having general formula (I) by cross-coupling boric acids, borine acids or boric anhydrides derived therefrom having general formula (II), in which x1, x2, x3 and x4 represent independently f...  
WO/1993/025530
A process and pharmaceutical compositions for treating several diseases and conditions which are normally treatable with retinoid-like compounds are disclosed where the compounds used for the treatment are substantially non-teratogenic a...  

Matches 401 - 450 out of 3,139